Gut Microbiota: Potential for a Unifying Hypothesis for Prevention and Treatment of Hypertension.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28546357.
- Also identified by DOI 10.1161/CIRCRESAHA.117.310734 and PMC identifier 5590108.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite major advances in pharmacological and device-based therapies, systemic hypertension (HTN) continues to be the major, modifiable risk factor for most cardiovascular disease and a leading cause of morbidity and mortality. Treatment resistant HTN (RH) is present in ≈15% to 20% of hypertensive patients, with few treatment options. These facts provide an opportunity to develop novel hypotheses to advance this field.
Medical subject headings
- Antihypertensive Agents
- Gastrointestinal Microbiome
- Hypertension
- Probiotics